What is the current valuation of the Japan facial rejuvenation market?

The market valuation was $780.56 Million in 2024. Read More

What is the projected market size for the Japan facial rejuvenation market by 2035?

The projected valuation for 2035 is $1335.0 Million. Read More

What is the expected CAGR for the Japan facial rejuvenation market during the forecast period 2025 - 2035?

The expected CAGR is 5.0% during the forecast period. Read More

Which segment had the highest valuation in the Japan facial rejuvenation market in 2024?

Non-Surgical Procedures had the highest valuation, ranging from $300.0 Million to $500.0 Million. Read More

What are the key players in the Japan facial rejuvenation market?

Key players include Allergan, Revance Therapeutics, Medytox, Galderma, Ipsen, Hugel, and Sientra. Read More

What is the valuation range for Botox Injections in the Japan facial rejuvenation market?

The valuation range for Botox Injections is between $250.0 Million and $400.0 Million. Read More

How does the market valuation for women compare to men in the Japan facial rejuvenation market?

The market valuation for women ranges from $390.28 Million to $676.0 Million, while for men it ranges from $156.14 Million to $273.0 Million. Read More

What is the valuation range for laser treatments in the Japan facial rejuvenation market?

The valuation range for laser treatments is between $130.56 Million and $235.0 Million. Read More

Which skin type segment shows the highest potential valuation in the Japan facial rejuvenation market?

The Combination Skin segment shows the highest potential valuation, ranging from $338.32 Million to $564.0 Million. Read More

What is the valuation range for surgical procedures in the Japan facial rejuvenation market?

The valuation range for surgical procedures is between $150.0 Million and $250.0 Million. Read More

Japan Facial Rejuvenation Market

ID: MRFR/HC/49496-HCR

200 Pages

Satyendra Maurya

Last Updated: February 06, 2026

Japan Facial Rejuvenation Market Research Report: Size, Share, Trend Analysis By Treatment Type (Surgical Procedures, Non-Surgical Procedures, Injectables, Laser Treatments), By Procedure Category (Facelift, Botox Injections, Dermal Fillers, Chemical Peels), By Skin Type (Aging Skin, Dry Skin, Oily Skin, Combination Skin) and By Target Group (Men, Women, Aging Population) - Growth Outlook & Industry Forecast 2025 To 2035

Japan Facial Rejuvenation Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Construction, BY Type (USD Million)
  1. 4.1.1 Surgical Procedures
  2. 4.1.2 Non-Surgical Procedures
  3. 4.1.3 Injectables
  4. 4.1.4 Laser Treatments
2. 4.2 Construction, BY Procedure Category (USD Million)
  1. 4.2.1 Facelift
  2. 4.2.2 Botox Injections
  3. 4.2.3 Dermal Fillers
  4. 4.2.4 Chemical Peels
3. 4.3 Construction, BY Skin Type (USD Million)
  1. 4.3.1 Aging Skin
  2. 4.3.2 Dry Skin
  3. 4.3.3 Oily Skin
  4. 4.3.4 Combination Skin
4. 4.4 Construction, BY Target Group (USD Million)
  1. 4.4.1 Men
  2. 4.4.2 Women
  3. 4.4.3 Aging Population
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Construction
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Construction
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Allergan (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Revance Therapeutics (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Medytox (KR) - remove duplicate entry.
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Galderma (CH)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Ipsen (FR)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Hugel (KR)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Medytox (KR)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Sientra (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Hugel (KR)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 JAPAN MARKET ANALYSIS BY TYPE
3. 6.3 JAPAN MARKET ANALYSIS BY PROCEDURE CATEGORY
4. 6.4 JAPAN MARKET ANALYSIS BY SKIN TYPE
5. 6.5 JAPAN MARKET ANALYSIS BY TARGET GROUP
6. 6.6 KEY BUYING CRITERIA OF CONSTRUCTION
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF CONSTRUCTION
9. 6.9 DRIVERS IMPACT ANALYSIS: CONSTRUCTION
10. 6.10 RESTRAINTS IMPACT ANALYSIS: CONSTRUCTION
11. 6.11 SUPPLY / VALUE CHAIN: CONSTRUCTION
12. 6.12 CONSTRUCTION, BY TYPE, 2024 (% SHARE)
13. 6.13 CONSTRUCTION, BY TYPE, 2024 TO 2035 (USD Million)
14. 6.14 CONSTRUCTION, BY PROCEDURE CATEGORY, 2024 (% SHARE)
15. 6.15 CONSTRUCTION, BY PROCEDURE CATEGORY, 2024 TO 2035 (USD Million)
16. 6.16 CONSTRUCTION, BY SKIN TYPE, 2024 (% SHARE)
17. 6.17 CONSTRUCTION, BY SKIN TYPE, 2024 TO 2035 (USD Million)
18. 6.18 CONSTRUCTION, BY TARGET GROUP, 2024 (% SHARE)
19. 6.19 CONSTRUCTION, BY TARGET GROUP, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY PROCEDURE CATEGORY, 2025-2035 (USD Million)
  3. 7.2.3 BY SKIN TYPE, 2025-2035 (USD Million)
  4. 7.2.4 BY TARGET GROUP, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

Japan Construction Market Segmentation

Construction By Type (USD Million, 2025-2035)

Surgical Procedures
Non-Surgical Procedures
Injectables
Laser Treatments

Construction By Procedure Category (USD Million, 2025-2035)

Facelift
Botox Injections
Dermal Fillers
Chemical Peels

Construction By Skin Type (USD Million, 2025-2035)

Aging Skin
Dry Skin
Oily Skin
Combination Skin

Construction By Target Group (USD Million, 2025-2035)

Men
Women
Aging Population

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”